Cancer Nexus Blog

Matthew Hemming, MD, PhD, is developing new therapies for gastrointestinal stromal tumors and other sarcomas. He is also identifying new biomarkers for assessing risk of tumor recurrence.

Jessica Spinelli, PhD, explains how tumor cells can survive without oxygen

Samantha Sarli and Jonathan Watts, PhD are working on a novel drug to treat glioblastoma.

The Cancer Research Office is commended for their outstanding performance — once again!

Shyam Patel, MD, PhD, explains a new method for detecting blood cancer before it takes root.

Sharon Cantor, PhD, explains why chemotherapy for hereditary breast and ovarian cancer doesn't always work as expected.

Jillian Richmond, PhD, discusses her T cell research and its application to diagnostics and therapies for lymphoma.

Follow Our Research Presentations at the AACR Annual Meeting 2022

UMass thoracic surgeons perform simulated surgery using a robotic platform to train for an emergency conversion to an open procedure.

David Cachia, MD talks about future neuro-oncology clinical trials at UMass Chan

A pilot study to develop new bioinformatic tools to identify fusion circRNAs in cancer has received funding from the UMass Cancer Center and PQHS

A study on the epigenetic vulnerabilities of metastatic breast cancer has received funding from the UMass Cancer Center

A pilot study to develop a unique approach to enhance immunotherapy for pancreatic cancer has received funding from the UMass Cancer Center

An early-stage research study of immunotherapy in melanoma has received funding from the UMass Cancer Center

UMass Cancer Center and PQHS fund a pilot study to develop new bioinformatic tools to identify fusion circRNAs in cancer

The UMass Cancer Research Office has received national recognition from ECOG-ACRIN for outstanding performance in clinical trials research

Dr. Patel discusses his new research defining the clinico-genomic landscape of TP53 mutations in patients with AML

By studying cancer in dogs, researchers at UMass Cancer Center are working to improve the outcomes and extend the lives of both human patients and pet dogs with cancer

UMass was selected as one of only a few sites around North America offering a phase I/II clinical trial involving intratumoral injection

Aiming to provide direct link between providers and physical activity programs to conduct patient referrals

Ceol 's lab have developed a drug that targets this factor and is currently testing whether it can combat drug resistance when used in combination with current therapies.

UMass Cancer Center researchers are developing new therapeutic treatments for melanoma that can be used alone or in combination with current therapies

Personalized digital technology to address smoking-related health disparities developed by UMass Cancer Center researcher

Our studies have discovered that the genome (DNA) editing tool known as CRISPR-Cas9 can efficiently induce somatic genome editing in the lungs of adult animals. We designed various delivery vectors that could effectively deliver CRISPR editing components.

Cancer Population Health Sciences research program investigates multi-level factors of cancer risk and treatment outcomes to implement effective cancer screening, prevention, and treatment